Literature DB >> 237346

Cyclic nucleotides as intracellular mediators of B cell activation.

J Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 237346     DOI： 10.1111/j.1600-065x.1975.tb00161.x

Source DB:  PubMed          Journal:  Transplant Rev        ISSN： 0082-5948


× No keyword cloud information.
  9 in total

1.  The lymphocyte plasma membrane: locus of control in the immune response.

Authors:  L M Jerry; A K Sullivan
Journal:  In Vitro       Date:  1976-03

2.  A general interactive model for B cell activation. I. The theory.

Authors:  A J Rosenspire; R Rosen; D M Jacobs
Journal:  Cell Biophys       Date:  1981-03

Review 3.  Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells.

Authors:  K L Richards; S D Douglas
Journal:  Microbiol Rev       Date:  1978-09

Review 4.  Immunocompetent cells in resistance to bacterial infections.

Authors:  P A Campbell
Journal:  Bacteriol Rev       Date:  1976-06

5.  Age associated changes in intracellular cyclic adenosine monophosphate.

Authors:  A Birkenfeld; A Ben-Zvi
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

6.  A general interactive model for B cell activation II. Experimental verification.

Authors:  A J Rosenspire; D M Jacobs
Journal:  Cell Biophys       Date:  1981-03

7.  Aldolase and adenosine deaminase activity in lymphocytes of patients with glomerulonephritis.

Authors:  M Klinger; Z Szewczyk; M Robak
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

8.  Activation of lymphocytes by brominated nucleoside and cyclic nucleotide analogues: implications for the "second messenger" function of cyclic GMP.

Authors:  M G Goodman; W O Weigle
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Molecular requirements for B-lymphocyte activation by Escherichia coli lipopolysaccharide.

Authors:  C R Raetz; S Purcell; K Takayama
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.